Lessons learned from the West African Ebola outbreak, Marion Koopmans, ERS 2015

Slides:



Advertisements
Similar presentations
Viral Haemorrhagic Fever: The West African Zaire Ebola Virus outbreak
Advertisements

Ebola Viral Disease October 21, Overview  Historical perspective  Current epidemic update  OSUWMC preparedness  Signage and marketing  Screening.
* Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans. * EBOLA is a rare but deadly virus.
What is Ebola? 10/12/2014. What is Ebola? Filoviridae Ebolavirus – 5 viruses/species – Ebola (Zaire) – Sudan – Bundibugyo – Tai Forest – Reston Marburgvirus.
Any of the following risk factors within 3 weeks (21 days) before onset of symptoms 1,2 : Contact with blood or other body fluids of a patient known to.
Ebola. What is Ebola?? Ebola is a rare and deadly disease caused by the infection of the Ebola Virus (5 strands) Ebola viruses are found in several African.
EVD is a preventable but often fatal viral infection An EVD outbreak is affecting countries in West Africa where disease control resources are very limited.
Transmission The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. Human-to-human.
Ebola Virus Disease. EVD Description Hemorrhagic fever with case fatality rate up to 90% Endemic areas: Central and West Africa Wildlife reservoir: bats.
How can Modeling Help in Emerging Epidemics? John Grefenstette, PhD Public Health Dynamics Lab Health Policy & Management Pitt Public Health Dec 5, 2014.
EBOLA OUTBREAK 2014 There has never been an outbreak this size and severity.
PRSENTATION ABOUT EBOLA BY -PARTH MONGA INFORMATION IS BASED UPON VARIOUS RESERCH MATERIALS, I HAVE ONLY COMPOSED IT.FOR THE PURPOSE OF CREATING AWARENESS-PARTH.
The current outbreak of Ebola in west Africa is both a public health emergency of international concern and a human tragedy.
©2014 MFMER | slide-1 GMCH, Louisville November 2014 Ebola!
Washington State Ebola Response: From Identify, Isolate and Inform to Frontline, Assessment and Treatment Scott Lindquist MD MPH State Communicable Disease.
2014 Ebola Virus Outbreak. What is a Virus? Viruses are microscopic particles (10 – 400 nm). Viruses are made of genetic material (DNA or RNA) surrounded.
INTEGRIS Preparedness Plan: Ebola Virus Disease (EVD) With the spread of Ebola to the U.S., ensuring our employees and communities are safe is the utmost.
INDONESIA PREPAREDNESS AND RESPONSE ON EBOLA VIRUS DISEASE Bangkok, 1 – 3 Desember 2014 Directorat General of Disease Control and Environmental Health.
Ebola Virus Disease, West Africa outbreak 2014 An update on cases 21/04/2015 To update slides with most recent figures, please follow links and instructions.
Network modeling of the Ebola Outbreak Ahmet Aksoy.
Ebola Facts October 15, 2014.
Ebola Virus Disease Dr. Oluwafemi Akinyele Popoola Lecturer and Consultant Community Physician Lecture delivered at Bodija-Ashi Baptist Church 14 th September,
Ebola Virus Outbreak This presentation has been prepared by Christine H. Herrmann, Ph.D. of the Department of Molecular Virology and Microbiology at Baylor.
Ebola virus  The Ebola virus causes an acute, serious illness which is often fatal if untreated.  The most severely affected countries are: Guinea,
Ebola virus disease. Key facts Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a severe, often fatal illness in humans. The.
Dr. Chaltu Wakijra Oromo Community Organization Washington, D.C April 4, 2015.
EBOLA Kyle Draves. Pathogen Zaire Ebola Virus  Also known as EBOV  One of five viruses of the genus Ebolavirus  EBOV is most virulent of the five;
EBOLA - ZAIRE. PPE – Personal Protection Equiptment.
Clinical Track – Day 1 Located in Murdock. Ebola: Past, Present, Future Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases.
Ebola Virus Disease Clinical manifestations Ebola Virus Disease Clinical manifestations N. Shindo Lead, Clinical & Infection Control Pandemic & Epidemic.
Ebola Epidemic in Coastal West Africa – Overall Situation Report given at Caritas Internationalis Briefing Meeting 05 November 2014 Dr and Deacon Timothy.
Latest WHO Update (22 Sept. 2014) Estimates 20k cases by 2 Nov. CDC says 1.4 M by Jan. 20 Up to 70% fatality rate Ages 14 – 44, older are most fatal Most.
 An acute, severe viral infection  First appeared in 1976 in two simultaneous outbreaks  in a village near the Ebola River in the Democratic Republic.
UGANDA HEALTHCARE EBOLA OUTBREAK ghU Presentation.
EBOLA HAEMORRHAGIC FEVER – BLEEDING FEVER 7NEWS EBOLA UPDATE.
Patrice Gordon, Family Nurse Practitioner Canadian Red Cross Emergency Response Unit Kenema Ebola Treatment Centre, Sierra Leone 1.
Training on the Ebola Virus Disease (duration 3 days)
A PRESENTATION BY: DETTA MOHAMAD ALNAAL JAMES BURGESS BUROOJ MUSHTAQ ANIMAN RANDHAWA Assignment 2: Ebola.
EBOLA VIRUS DISEASE PREPAREDNESS Screening, Detection & Planning.
Emerging Diseases Lecture 9: Filoviruses 9.1 Overview 9.2: Outbreaks: Marburg, N’zara, Yambuku, Reston, Kikwit, West Africa 9.3 Summary.
EBOLA. WHAT IS EBOLA? ◊Virus, from fruit bat ◊No vaccine, no cure for the moment ◊2-21 days from infection until symptoms show ◊Symptoms are similar to.
Outbreaks and Epidemics Ebola Hemorrhagic Fever. Ebola facts and origins  Ebola hemorrhagic fever is a severe, often-fatal disease in humans and nonhuman.
John J. Lanza, MD, PhD, MPH, FAAP Florida Department of Health A Public and Clinical Health Perspective.
Take The Quiz. -Ebola is a severe, often fatal illness in humans -The virus was transmitted to people from wild animals and spreads in the human population.
Filoviruses. Filoviruses (Filoviridae) Marburg and Ebola viruses filamentous, enveloped, negative-strand RNA viruses. These agents cause severe or fatal.
Ebola Virus Outbreak, 2014 Dr. Md. Shakeel Waez Asst. Professor (Medicine) Chittagong Medical College.
Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a severe, often fatal illness in humans. The virus is transmitted to people.
Ebola By Jakob Bengtsson and Sturla Slotsvik. Introduction Ebola is a viral disease which affect humans and other primates Ebola is a viral disease which.
Ebola. Discovery 1976 near Ebola River Valley in Africa.
Ebola Virus BY: HEATHER BRANDSTETTER SAMANTHA LACLAIR JENNA HENSEL DANIELLE GILFUS.
EBOLA 2014 OUTBREAK, EXPERIMENTAL TREATMENTS AND RISK MANAGEMENT 1.
Ebola virus disease - Transmission through body fluids; perspectives from outbreak response in Liberia Dr Margaret Fitzgerald Public Health Medicine.
Information on the Ebola surge in West Africa All you need to know about Ebola (HF) -Jazlyn Selvasingh.
The Hot Zone By Richard Preston
Ebola SITREP and Response—2014 Matt Richardson, DrPH, MPH Health Director Denton County Health Department Jody Gonzalez Chief Denton County Emergency Services.
Conférence internationale Africa 2013 sur l’Ecosanté Ebola risk in the pig value chain in Uganda Christine Atherstone¹, Kristina Roesel¹, Dr. Delia Grace².
DR I.O.LAWAL MBChB(Ife),FWACS(Urol). EBOLA VIRUS DISEASE Introduction Epidemiology Transmission Signs & Symptoms Diagnosis Differentials Treatment/ Health.
Molecular Evolution and Ebola
Ebola Facts October 14, 2014.
Ebola Virus and development
Ebola Facts October 14, 2014.
Ebola Virus Disease (EVD) WHAT IS IT?
Ebola Facts October 14, 2014.
EBOLA VIRUSES (SYMPTOMS, TREATMENT AND CAUSES) Nama : Siti Sofea Annisa Binti Sheikh Mohamad No. Matric : Lecturer : Madam Siti Wahida Binti.
Molecular Evolution and Ebola
Marburg, N’zara, Yambuku, Reston, Kikwit, West Africa
Capitol region Emergency Planning Council: ESF#8
Ebola Facts October 14, 2014.
Ebola Facts October 15, 2014.
Ebola Facts October 14, 2014.
Presentation transcript:

Lessons learned from the West African Ebola outbreak, Marion Koopmans, ERS 2015

Wilson, M.L., Ecology and infectious disease, in Ecosystem Change and Public Health: A Global Perspective, J.L. Aron and J.A. Patz, Editors. 2001, Johns Hopkins University Press: Baltimore. p

F Keesing et al. Nature 468, (2010) doi: /nature09575 Drivers and locations of emergence events for zoonotic infectious diseases in humans from 1940–2005.

Probability of further spread greatly increased Population growth Global travel and trade

Probability of stage 2 and 3 infection depends on: 1.Host abundance 2.Fraction infected 3.Frequency of 'encounters’ 4.Probability of transmission per encounter phylo distance host microbe's characteristics Host characteristics Wolfe et al., 2007

Start outbreak EBOV  March 10, 2014 notification unknown disease characterized by fever, severe diarrhea, vomiting and high fatality rate in Guéckédou and Macenta in Guinea.  March 22, EVD reported by Guinea to WHO.  March 27, EVD suspected cases in Liberia and Sierra Leone related to outbreak in Guinea.  April 3d: ZEBOV Dx * Time to diagnosis: > 3 weeks

Gastro-enteritis syndrome at clinical presentation High case fatality rate First outbreak in West Africa Baize et al. 2014

< 2 yr old < seeding through HCW Diagnose

Feldmann and Geisbert, 2011 Family Filoviridae genus Marburg viruses Genus Ebolaviruses. Genus Cueva viruses (Spain, New) 5 species:  Sudan (SUDV)  Zaire (EBOV)  Tai Forest (TAFV)  Bundibugyo (BDBV)  Reston (RESTV) Case fatality rate 0-70% Zaire EBOV highest

Soluble GP, frequency depends on sequence specific RNA editing (Mohan et al., 2012) 2.2 × × nucleotide substitutions/site/year (Caroll et al., 2013)

Animal surveillance for Ebola, Gabon Rouquet et al., 2005 Outbreaks in animals detected prior to (4/5) human disease outbreaks Convincing evidence for bushmeat related introductions Fruit bats Duikers Primates

Saez et al., EMBO Mol Med, 2014 Single zoonotic event in Meliandou, bat-borne, followed by human2human transmisison

Fruit Bats as reservoir for EBOV Leroy et al., 2005 Overlapping ecological niche No symptoms Infection cyclical Potential source of introduction into West Africa

Potential under-reporting of Ebola (Schoepp et al., 2014)

Initial factors contributing to Ebola outbreak  Bush meat consumption  Outbreak in new region  Non-specific syndrome  Poor healthcare sector, delayed diagnostics  Lack of PPE and training  Cultural beliefs > seemingly uncontrollable spread

Shedding kinetics Ebola Towner et al., 2004; Ksiazeck et al., 1999; Reusken et al., Fatal cases higher loads than survivors 2.Early cases can test negative (depending on detection limit of assay) 3.Late samples can test negative, but whether these persons could transmit is unknown 4.Fatal cases rarely mount antibody response 5.Are the data the same for the current strain?

Courtesy of Pierre Rolin, US CDC

Nosocomial Tx Ebola Ftika et al., Ebola Sudan, 2013  AR Unprotected contact HCW 81%  Limited physical contact HCW 21%  Visiting same room 0% Baron et al., Ebola Sudan 1983  Unprotected HCW, nursing 67%  Unprotected HCW, contact, no nursing 13% Francesconi et al., Uganda, 2013  Contact body fluids p<  Funeral ritual p< 0.02  Sharing meal, room, no increased risk Borchert et al., Marburg outbreak, 2007  Non-invasive procedures: 19% consistent use of PPE  Invasive procedures: 29% consistent use of PPE Direct contact Body fluids of severely ill and deceased patients No airborne Tx > Contact precautions Quarantine Safe burials

WHO, NEJM, 2014; Kilmarx et al., 2014 Mackay, based on WHO reports Exponential growth phase Ro estimates: Liberia 1.5 Sierra Leone 1.4 Guinee 1.8 Shifting factors contributing to HCAI: Awareness>availability of PPE>contact in social environment>fatigue 9% of total health workforce!

Incidence of Ebola, HCW Sierra Leone, May-October 3,854 cases Of these, 199 HCW Population: 80.4 per 100,000 (1 in 1250) HCW: 8,285 per 100,000 (1 in 12) Kilmarx et al., 2014

Nosocomial transmission outside region Toth et al., 2015 transmissions/case: 0.46 outside Africa: 0.17 Sierra Leone: 0.05

Chevallier et al., 2014

contagious-is-ebola How infectious is ebola?

Control strategy  Rapid case finding and ascertainment  Local outbreak teams, laboratory capacity  Isolation  Holding centres, triage units, lab capacity  Contact tracing  Outbreak teams  Decontamination  Treatment  Massive fluid replacement, electrolytes, malaria  Social mobilization  Certificates, education, patient care, post ebola care  Surveillance  Swab teams

Nrs 175, 179, and 183 on the UN human development index (ranked from 1-185) UN Human development index 2013http://issuu.com/undp/docs/hdr14- report-en?e= / #search

Location of treatment centres

Big challenge: treatment and vaccine trials

Conclusions  The Ebola outbreak is a clear example of the changing epidemiology of emerging infections  Ebola greatly overwhelmed local health infrastructures  Long term stable and prepared infrastructures needed to address EID threats  Forward thinking in terms of vaccine and drug development needed for low probability high impact diseases